Source: Market Watch
The Food and Drug Administration said Monday that it has withdrawn the emergency use authorization granted to hydroxychloroquine and chloroquine during the COVID-19 pandemic.
The federal agency had issued the EUA in March, allowing some patients with COVID-19 to be treated with the drugs when used from a federal stockpile.
A number of clinical trials evaluating the drugs have failed, and the emerging scientific consensus has indicated that the drugs, which are approved to treat lupus, malaria, and rheumatoid arthritis, do not benefit patients with COVID-19 and may cause additional health risks.
The messaging around hydroxychloroquine has been further complicated by an inaccurate study that found the drugs harmed patients.
Full Story @ MarketWatch
Discover more from News Facts Network
Subscribe to get the latest posts sent to your email.
